Since the beginning of the pandemic caused by the severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) the gastrointestinal (GI) tract has emerged as an important …

Respiratory and gastrointestinal symptoms are the predominant clinical manifestations of the
coronavirus disease 2019 (COVID-19). Infecting intestinal epithelial cells, the severe acute …

Abstract Background Coronavirus disease 2019 (COVID-19) is an emerging serious global
health problem. Gastrointestinal symptoms are common in COVID-19 patients, and severe …

Background Long-term complications after COVID-19 are common, but the potential cause
for persistent symptoms after viral clearance remains unclear. Objective To investigate …

Protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
and associated clinical sequelae requires well-coordinated metabolic and immune …

The ongoing global pandemic of COVID-19 disease, which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and …

COVID-19 is mainly associated with respiratory distress syndrome, but a subset of patients
often present gastrointestinal (GI) symptoms. Imbalances of gut microbiota have been …

The SARS-CoV-2-associated COVID-19 pandemic has shaken the global healthcare
system. Although the best-known symptoms are dry cough and pneumonia, viral RNA has …

Long-term sequelae of coronavirus disease (COVID)-19 are frequent and of major concern.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the host …

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has spread rapidly worldwide, seriously endangering human …